WOAH

Blacksmith Medicines and Zoetis Announce Research Collaboration for Novel Animal Health Antibiotics

Retrieved on: 
Wednesday, February 14, 2024

SAN DIEGO, Feb. 14, 2024 /PRNewswire/ -- Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing medicines targeting metalloenzymes, and Zoetis, the world's leading animal health company, announced today a collaboration to discover and develop novel antibiotics for animal health.

Key Points: 
  • SAN DIEGO, Feb. 14, 2024 /PRNewswire/ -- Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing medicines targeting metalloenzymes, and Zoetis, the world's leading animal health company, announced today a collaboration to discover and develop novel antibiotics for animal health.
  • Blacksmith and Zoetis will collaborate to discover and develop novel antibiotics to selectively target bacteria for animal health," said Zachary Zimmerman, Ph.D., CEO and co-founder of Blacksmith.
  • "As part of our commitment to reduce the dependency on antibiotic classes shared with human health, we are pleased to leverage our veterinary expertise along with our extensive collection of pathogens in this collaboration with Blacksmith," said Dr. Jeff Watts, Research Director, External Innovation at Zoetis.
  • "Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock."

Trupanion Reconvenes Council on Animal Health to Provide Update on ‘Mystery’ Canine Respiratory Illness

Retrieved on: 
Tuesday, January 30, 2024

The session will provide the latest insights into the current state of canine respiratory illness in North America, and follows the exceptional interest generated by their November 2023 event.

Key Points: 
  • The session will provide the latest insights into the current state of canine respiratory illness in North America, and follows the exceptional interest generated by their November 2023 event.
  • Additionally, the panel will evaluate the gravity of respiratory cases, as indicated by reported canine mortality rates, and provide invaluable guidance for pet parents and the veterinary community alike.
  • Canine Respiratory Illness: A Data-Driven Update marks the seventh Trupanion-led event that seeks to deliver real-time pet and public health data to viewers, with cumulative viewership surpassing 6 million.
  • “Trupanion exists to bring comfort in times of uncertainty” said Dr. Steve Weinrauch, Trupanion’s Chief Veterinary and Product Officer.

Alveo Technologies Is Developing Groundbreaking Avian Influenza Molecular Test for Poultry in Partnership with x-OvO, Royal GD, and Pharmsure

Retrieved on: 
Tuesday, January 9, 2024

ALAMEDA, Calif., Jan. 9, 2024 /PRNewswire/ -- Alveo Technologies, Inc. (Alveo), a leader in molecular sensing and diagnostics with its proprietary be.well technology platform, today announced it is working with experts and leaders in the poultry industry to launch a rapid, accurate, in-the-field multiplex panel to test for all relevant strains of avian influenza, initially focusing on Group A, H5, H7, and H9. To help codevelop and distribute the tests, Alveo has partnered with industry leaders x-OvO, Royal GD, and Pharmsure International Ltd. The company expects to release their first product in the poultry diagnostic space, in EMEA in the first half of 2024.  

Key Points: 
  • To help codevelop and distribute the tests, Alveo has partnered with industry leaders x-OvO, Royal GD, and Pharmsure International Ltd.
  • The avian flu test will be Alveo's first product to launch into the agricultural sector since Alveo announced its open platform and partnering strategy last year.
  • In addition to avian flu, Alveo is partnering to develop test panels for many other pathogens impacting the agriculture industry.
  • "We've been working closely with Alveo in a deep collaboration to develop these highly valuable assays for Avian Influenza," said Wim Kieftenbeld, Director Business Development at Royal GD.

Global Veterinary Authorities Delve into Trupanion Data, Gaining Insight into Current Canine Respiratory Illness Concerns

Retrieved on: 
Tuesday, November 28, 2023

Trupanion’s real-time pet health data allows for unique insights into pet health patterns by age, breed, sex, state, and neighborhood.

Key Points: 
  • Trupanion’s real-time pet health data allows for unique insights into pet health patterns by age, breed, sex, state, and neighborhood.
  • These high level and granular vantage points enable unique visibility into potential health-related patterns, both within and beyond the conventional norms.
  • Trupanion will host a live canine respiratory illness Q&A “Separating Fact, Fiction, and Uncertainty” on November 30.
  • Trupanion's Chief Veterinary/Product Officer, Dr. Steve Weinrauch is available to share canine respiratory illness related insights or to provide context regarding pet health data as it relates to the extensive Trupanion database.

STATEMENT - Domestic dog tests positive for avian influenza in Canada

Retrieved on: 
Tuesday, April 4, 2023

The domestic dog was found to have been infected with avian influenza after chewing on a wild goose, and died after developing clinical signs.

Key Points: 
  • The domestic dog was found to have been infected with avian influenza after chewing on a wild goose, and died after developing clinical signs.
  • Based on the current evidence in Canada, the risk to the general public remains low and current scientific evidence suggests that the risk of a human contracting avian influenza from a domestic pet is minor.
  • Furthermore, no domestically acquired human cases of avian influenza have been reported in Canada.
  • We are tracking avian influenza activity in Canada and around the world, with domestic and international partners, including the World Health Organization.

Government of Canada announces up to $45.3 million to enhance African swine fever prevention and preparedness

Retrieved on: 
Friday, August 26, 2022

To help ensure high levels of vigilance in the face of the threat of African swine fever, the Government of Canada is investing up to $23.4 million to support the pork industry's prevention and mitigation efforts.

Key Points: 
  • To help ensure high levels of vigilance in the face of the threat of African swine fever, the Government of Canada is investing up to $23.4 million to support the pork industry's prevention and mitigation efforts.
  • In addition, up to $19.8 million will be invested in the Canadian Food Inspection Agency's (CFIA) prevention and preparedness efforts.
  • Although Canada has never had a case of ASF, the disease continues to spread in several regions around the world.
  • "We must continue to work as a team - federal, provincial and territorial governments together with industry, to prevent African swine fever from entering the country.

Apple Rush Company, Inc. announces the acquisition of Wild Organic Ancient Horticulture Hemp Nursery, a boutique grower of Organic Hemp Flower

Retrieved on: 
Monday, May 2, 2022

TITUSVILLE, Fla., May 2, 2022 /PRNewswire/ -- TheApple Rush Company, Inc. (OTC PINK: APRU) (the "company") has acquired Wild Organic Ancient Horticulture (WOAH) in Spring Hill Florida.

Key Points: 
  • TITUSVILLE, Fla., May 2, 2022 /PRNewswire/ -- TheApple Rush Company, Inc. (OTC PINK: APRU) (the "company") has acquired Wild Organic Ancient Horticulture (WOAH) in Spring Hill Florida.
  • WOAH is an organic no till farming operation that brings APRU the flower growing operation necessary for our seed to sale hemp program.
  • Tony Torgerud, CEO of Apple Rush, stated, "This acquisition provides us with organic farmers who have a passion to grow the best products in the industry.
  • APRU, with a complete team of professional farmers growing hemp, will deliver excellent growth opportunities for us in the future.